|
1.
|
Aged between 19 and 65 years
|
1.
|
Taking medications to control blood pressure
|
|
2.
|
Pre- or stage 1 hypertension (JNC 7)
|
2.
|
Secondary hypertension
|
| |
-Systolic blood pressure between 120 and 159 mmHg
|
3.
|
History of cerebrovascular disease, cardiovascular disease, malignant tumors, kidney diseases, liver diseases, thyroid gland diseases, active tuberculosis, or other infectious diseases
|
| |
- Diastolic blood pressure between 80 and 99 mmHg
|
4.
|
Diabetic patients taking insulin or anti-diabetic medications
|
|
3.
|
The participants are volunteers and written consent obtained
|
5.
|
Drug or alcohol dependence
|
| | |
6.
|
Taking hemorrhagic disease and anticoagulation medications (excluding aspirin)
|
| | |
7.
|
Receiving systemic steroid therapy or immunosuppressive therapy
|
| | |
8.
|
Taking medications that could affect blood pressure such as central nervous system depressants or stimulants
|
| | |
9.
|
Pregnancy or the possibility of pregnancy
|
| | |
10.
|
Hypersensitivity reactions following moxibustion therapy
|
| | |
11.
|
Received oriental medicine treatment related to hypertension in the past month
|
| | |
12.
|
Participants deemed unsuitable for the trial, as judged by the person in charge of the clinical trial.
|
